Stock overview
PTC Therapeutics, Inc.
Explore the company, reported ownership, price history, and available source evidence.
PTC Therapeutics, Inc. (PTCT) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $62.67
- · PTCT
- Tracked holders
- 3 funds
- Latest available 13F per fund
PTCT · USD
Price
$62.67
+$23.75
(+61.02%)
over selected range
Close · Sep 25, 2026
Market closed
1255 stored daily closes
$62.67
Sep 25, 2026
- Range low
- $18.07
- Range high
- $89.55
- Observations
- 1255
- Session date
- Sep 25, 2026
Sep 27, 2021–Sep 25, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Renaissance Technologies largest tracked holder Q2 2026 · filed Aug 13, 2026 · SEC filing | +36% 26'Q2 | $59,015,895 | 0.08% |
| Polen Capital Management position history Q2 2026 · filed Aug 4, 2026 · SEC filing | Newly reported 26'Q2 | $2,032,398 | 0.02% |
| Tudor Investment Corp position history Q2 2026 · filed Aug 14, 2026 · SEC filing | −67% 26'Q2 | $1,120,690 | 0% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market